Electronic Health Record (EHR) companies have historically used proprietary formats to lock in customers. AI's ability to read and translate unstructured data from any source effectively breaks these data silos, finally making patient data truly portable.

Unlike other sectors that invested heavily in workflow SaaS, healthcare's lack of investment means it has less technical debt. This allows a direct jump to AI-native systems, avoiding a costly "rip and replace" cycle and overcoming sunk-cost bias that plagues other industries.

We possess millions of data points on interventions, but they are useless to AI models because they're trapped in thousands of disparate EMRs in varied formats. The challenge is not generating more data, but solving the human incentive and alignment problems required to create unified data registries.

The future of integration isn't about pre-building every connection. AI agents will perform "integration on demand," stitching systems together at runtime to answer a specific user query. This transforms a slow, expensive IT function into a fluid, dynamic part of everyday work.

Many MedTech firms rush to AI, but serial entrepreneur Nader Fahy warns this solves the wrong problem. The foundational issue is fragmented systems across compliance, engineering, and operations. Without a unified data foundation, AI cannot be effective and may introduce risks, making integration the top priority.

Beyond simple Q&A or report generation, the most transformative application of AI is "agenting AI." This concept describes an autonomous co-worker operating in the background to monitor systems, identify issues, and execute tasks without direct human prompting, bringing a new level of efficiency to the industry.

Chronic disease patients face a cascade of interconnected problems: pre-authorizations, pharmacy stockouts, and incomprehensible insurance rules. AI's potential lies in acting as an intelligent agent to navigate this complex, fragmented system on behalf of the patient, reducing waste and improving outcomes.

Traditional automation focuses on discrete tasks, while Agentic AI represents a paradigm shift toward orchestrating entire end-to-end processes. It understands objectives, interacts with multiple systems, and coordinates actions across teams, moving from simply executing a task to driving an entire workflow forward.

Vendors frequently introduce isolated agents for specialized tasks like safety analysis and data reconciliation into pharma tech stacks. Real operational value emerges only when an overarching orchestration layer coordinates these disparate agents within strict permission boundaries and clinical workflows.